The metabolic profile shed the light on the potential use of V. pubescens bark for the treatment of Alzheimer’s disease as evidenced by the promising in-vitro antioxidant and in-vitro acetylcholinesterase inhibitory activity assessed herein. This evidence concerns the gene ACHE and early-onset autosomal dominant Alzheimer disease.